Brown, Lisle/Cummings, Inc. Abb Vie Inc. Transaction History
Brown, Lisle/Cummings, Inc.
- $335 Billion
- Q4 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 28,038 shares of ABBV stock, worth $5.76 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
28,038
Previous 28,091
0.19%
Holding current value
$5.76 Million
Previous $5.55 Billion
10.19%
% of portfolio
1.49%
Previous 1.69%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
4,111Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$35.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$28 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.6 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.15 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $363B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...